Harbour HCAb PLUS™ is an innovative platform by Nona Biosciences that enhances the potential of heavy chain-only antibodies (HCAbs), allowing for diverse therapeutic applications, including bi-specific and multi-specific antibody formations. This platform is designed for superior efficacy in targeted drug delivery systems. Explore more about this cutting-edge technology at https://nonabio.com/en/harbour.html .
#harbourhcabplus #biopharmaceuticals #innovativetherapy #nonabiosciences
Like
Comment
Share
